Table 2. Symptoms, treatment, and outcomes for patients with COVID-19.

Items	Mild, n = 3	Moderate, n = 3	Severe, n = 3	Critical, n = 2	Total, n = 11
Symptom
Fever (%)	2 (66.7)	3 (100)	2 (66.7)	2 (100)	9 (81,8)
Sore throat (%)	0 (0)	2 (66.7)	2 (66.7)	0 (0)	4 (36.4)
Cough (%)	0 (0)	1 (33.3)	2 (66.7)	1 (50)	4 (36.4)
Dyspnea (%)	0 (0)	1 (33.3)	1 (33.3)	2 (100)	4 (36.4)
Runny nose (%)	1 (33.3)	1 (33.3)	0 (0)	1 (50)	3 (27.3)
Phlegm (%)	0 (0)	0 (0)	2 (66.7)	1 (50)	3 (27.3)
Nausea (%)	0 (0)	1 (33.3)	1 (33.3)	1 (50)	3 (27.3)
Malaise (%)	0 (0)	1 (33.3)	1 (33.3)	1 (50)	3 (27.3)
Headache (%)	0 (0)	0 (0)	1 (33.3)	0 (0)	1 (9.1)
Chills (%)	0 (0)	0 (0)	1 (33.3)	0 (0)	1 (9.1)
Diarrhea (%)	0 (0)	0 (0)	1 (33.3)	0 (0)	1 (9.1)
Abdominal bloating (%)	0 (0)	0 (0)	1 (33.3)	0 (0)	1 (9.1)
Treatment
Oxygen (%)	0 (0)	0 (0)	3 (100)	2 (100)	5 (45.5)
LPV/r (%)	0 (0)	0 (0)	3 (100)	2 (100)	5 (45.5)
Mechanical ventilation (%)	0 (0)	0 (0)	0 (0)	2 (100)	2 (18.2)
ECMO (%)	0 (0)	0 (0)	0 (0)	2 (100)	2 (18.2)
Steroid (%)	0 (0)	0 (0)	1 (33.3)	2 (100)	3 (27.3)
Interferon α2a (%)	0 (0)	0 (0)	0 (0)	1 (50)	1 (9.1)
Duration of fever (range)	2 (0-5)	6 (1-12)	6 (6-19)	23.5 (16-31)	6 (0-31)
30-day mortality	0 (0)	0 (0)	0 (0)	1 (50)	1 (9.1)

LPV/r, lopinavir/ritonavir; ECMO, extracorporeal membrane oxygenation.